Acquired Immunodeficiency Syndrome clinical trials

Explore recruiting acquired immunodeficiency syndrome clinical trials.

Recruiting acquired immunodeficiency syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acquired Immunodeficiency Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects

Czechia

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A single-arm phase II study of cetuximab plus platinum and taxane-based chemotherapy followed by AVElumab and Cetuximab as first-line therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients with PD-L1 combined positive score (CPS)≥1≤19: the immunotherapy.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase IIIb, multi-center, non-randomized, parallel-group, open-label, hybrid type I study evaluating the efficacy, safety, implementation effectiveness, and patient-reported outcomes of oral dolutegravir/lamivudine once-daily as a first-line regimen followed by participant-determined optional switch to long-acting intramuscular cabotegravir plus rilpivirine every two months for the maintenance of virologic suppression in antiretroviral therapy naive adults living with HIV-1.

Italy, France, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acquired Immunodeficiency Syndrome trials by city

Acquired Immunodeficiency Syndrome in Toronto Acquired Immunodeficiency Syndrome in Vancouver Acquired Immunodeficiency Syndrome in Montreal Acquired Immunodeficiency Syndrome in Calgary Acquired Immunodeficiency Syndrome in Edmonton Acquired Immunodeficiency Syndrome in Ottawa Acquired Immunodeficiency Syndrome in Winnipeg Acquired Immunodeficiency Syndrome in Quebec City Acquired Immunodeficiency Syndrome in Hamilton Acquired Immunodeficiency Syndrome in Kitchener Acquired Immunodeficiency Syndrome in London Acquired Immunodeficiency Syndrome in Halifax Acquired Immunodeficiency Syndrome in New York Acquired Immunodeficiency Syndrome in Los Angeles Acquired Immunodeficiency Syndrome in Chicago Acquired Immunodeficiency Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease